IR 07200202/2030001

From kanterella
Revision as of 22:17, 12 October 2023 by StriderTol (talk | contribs) (StriderTol Bot change)
Jump to navigation Jump to search
Capital Cardiology, P.C. - NRC Forms 591M and 592M, Inspection Report 03037572/2023001 (Safety)
ML23284A334
Person / Time
Site: 07200202, 03010772
Issue date: 09/19/2023
From: Tindle-Engelmann E
NRC/RGN-III/DRSS
To: Kritzman M
Capital Cardiology, PC
References
IR 2023001
Download: ML23284A334 (1)


Text

NRC FORM 591M U.S. NUCLEAR REGULATORY COMMISSION (04-2022)

Materials Inspection Report 1. Licensee/Location Inspected: 2. NRC/Regional Office Capital Cardiology, P.C.

1200 E Michigan Ave.

Lansing, MI Select location (Use keyboard arrows to select) . .

Report Number(s) 2023001 3. Docket Number(s) 4. License Number(s) 5. Date(s) of Inspection 03037572 21-32677-01 September 19, 2023 LICENSEE:

The inspection was an examination of the activities conducted under your license as they relate to radiation safety and to compliance with the Nuclear Regulatory Commission (NRC) rules and regulations and the conditions of your license. The inspection consisted of selective examinations of procedures and representative records, interviews with personnel, and observations by the inspector. The inspection findings are as follows:

1. Based on the inspection findings, no violations were identifie . Previous violation(s) close . During this inspection, certain of your activities, as described below and/or attached, were in violation of NRC requirements, and were assessed at Severity Level IV, in accordance with the NRC Enforcement Polic A. The violation(s), specifically described to you by the inspector as non-cited violations, are not being cited because they were self-identified, non-repetitive, corrective action was or is being taken, and the remaining criteria in the NRC Enforcement Policy were satisfie (Non-cited violation(s) was/were discussed involving the following requirement(s)

B. The following violation(s) is/are being cited in accordance with NRC Enforcement Policy. This form is a NOTICE OF VIOLATION, which may be subject to posting in accordance with 10 CFR 19.1 (Violations and Corrective Actions)

Statement of Corrective Actions I hereby state that, within 30 days, the actions described by me to the Inspector will be taken to correct the violations identified. This statement of corrective actions is made in accordance with the requirements of 10 CFR 2.201 (corrective steps already taken, corrective steps which will be taken, date when full compliance will be achieved). I understand that no further written response to NRC will be required, unless specifically requeste TITLE PRINTED NAME SIGNATURE AND DATE LICENSEE'S REPRESENTATIVE NRC INSPECTOR Elizabeth Tindle-Engelmann Elizabeth D. Tindle-Engelmann Digitally signed by Elizabeth D. Tindle-Engelmann Date: 2023.09.25 10:42:53 -05'00'

BRANCH CHIEF Rhex Edwards Digitally signed by Rhex A. Edwards Date: 2023.10.09 08:41:59 -05'00'

Add Continuation Page Page 1 of 1

NRC FORM 592M U.S. NUCLEAR REGULATORY COMMISSION (10-04-2022)

Materials Inspection Record 1. Licensee Name: 2. Docket Number(s): 3. License Number(s)

Capital Cardiology, . Report Number(s): 5. Date(s) of Inspection:

2023001 September 19, 2023 6. Inspector(s): 7. Program Code(s): 8. Priority: 9. Inspection Guidance Used:

Elizabeth Tindle-Engelmann 02201 5 87130 10. Licensee Contact Name(s): 11. Licensee E-mail Address: 12. Licensee Telephone Number(s):

Michelle Kritzman, RSO mkritzman@mpcphysics.com 734-662-3197 13. Inspection Type: Initial 14. Locations Inspected: Hybrid 15. Next Inspection Date (MM/DD/YYYY):

Routine Announced Main Office Field Office Normal Extended 09/19/2028 Non-Routine Unannounced Temporary Job Site Remote Reduced No change 16. Location(s) Inspected List:

1200 E Michigan Ave., Lansing, MI 17. Scope and Observations:

The licensee was a medical facility with authorization for diagnostic uses of byproduct material pursuant to 10 CFR 35.200. The licensee utilized an external consultant to serve as the radiation safety officer and perform program oversight. The licensee had one full-time nuclear medicine technologist. The licensee administered approximately 10 SPECT doses per day. The department received unit doses of primarily technetium-99m from a licensed radiopharmacy.

The inspector observed dose preparation and administration and package receipt. The licensees staff demonstrated decay in storage procedures and spill response. Interviews with licensee personnel indicated adequate knowledge of radiation safety and security concepts and procedures. The inspector reviewed the following records: area surveys, dose calibrator calibrations, dosimetry, package receipt, package return, program reviews, sealed source inventory and leak tests, spill reports, training, and waste logs.

Independent surveys were performed using a RadEye G (SN: 30653; calibration due: 5/9/2024). Results were consistent with the licensees survey records and postings.

No violations were identified as a result of this inspection.

Signature and Date - Branch Chief Digitally signed by Rhex A. Edwards Date: 2023.10.09 08:41:41 -05'00'

NRC Form 592M (10-04-2022) Page 1 of 1